Marcis Leja Selected Research

Pepsinogen A (Pepsinogen)

5/2022	Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study.
1/2022	Lifestyle and dietary factors associated with serologically detected gastric atrophy in a Caucasian population in the GISTAR study.
10/2020	Does Family History of Cancer Influence Undergoing Screening and Gastrointestinal Investigations?
9/2020	Sociodemographic, Lifestyle and Medical Factors Associated with Helicobacter Pylori Infection.
1/2020	Regional variations in Helicobacter pylori infection, gastric atrophy and gastric cancer risk: The ENIGMA study in Chile.
12/2019	Prevalence of Atrophic Gastritis in Kazakhstan and the Accuracy of Pepsinogen Tests to Detect Gastric Mucosal Atrophy.
1/2019	Sex differences in the prevalence of Helicobacter pylori infection: an individual participant data pooled analysis (StoP Project).
8/2017	Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study.
8/2017	Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays.
10/2014	Gastric cancer: prevention, screening and early diagnosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcis Leja Research Topics

Disease

29	Stomach Neoplasms (Stomach Cancer) 06/2022 - 01/2010
18	Neoplasms (Cancer) 01/2021 - 01/2012
16	Infections 06/2022 - 10/2008
15	Atrophy 06/2022 - 11/2009
6	Atrophic Gastritis 02/2022 - 08/2011
4	Carcinogenesis 12/2020 - 10/2010
2	Celiac Disease (Celiac Sprue) 04/2015 - 06/2011
2	Peptic Ulcer (Peptic Ulcers) 12/2013 - 12/2011
1	Nasopharyngeal Carcinoma 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2020
1	Colorectal Neoplasms (Colorectal Cancer) 11/2020
1	Hypersensitivity (Allergy) 06/2020
1	Prostatic Neoplasms (Prostate Cancer) 10/2019
1	Adenocarcinoma 08/2018
1	Hemorrhage 09/2017
1	Ulcer 09/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016
1	Asthma (Bronchial Asthma) 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Inflammation (Inflammations) 01/2014
1	Helicobacter Infections 02/2012
1	Achlorhydria (Hypochlorhydria) 02/2012
1	Metaplasia 01/2012
1	Gastritis 04/2011

Drug/Important Bio-Agent (IBA)

14	Pepsinogen A (Pepsinogen)IBA 05/2022 - 11/2009
13	Biomarkers (Surrogate Marker)IBA 06/2022 - 11/2009
6	AntibodiesIBA 06/2022 - 11/2009
6	Immunoglobulin G (IgG)IBA 01/2021 - 11/2009
6	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2014
5	Volatile Organic CompoundsIBA 01/2018 - 12/2013
4	Pepsinogen CIBA 01/2022 - 11/2009
4	PepsinogensIBA 01/2020 - 12/2012
3	Immunoglobulin A (IgA)IBA 01/2021 - 11/2009
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 11/2009
2	AntigensIBA 01/2021 - 12/2014
2	Drinking WaterIBA 09/2020 - 09/2018
2	SiliconIBA 01/2016 - 02/2015
2	GliadinIBA 04/2015 - 06/2011
2	gastrin 17 (G 17)IBA 04/2011 - 11/2009
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	Proton Pump InhibitorsIBA 01/2022
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	EnzymesIBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	SaltsIBA 01/2021
1	ORALIT (ORS)IBA 12/2020
1	Long Noncoding RNAIBA 12/2020
1	Adenosine Triphosphatases (ATPase)IBA 11/2020
1	Tumor Biomarkers (Tumor Markers)IBA 11/2020
1	Penicillins (Penicillin)FDA Link 06/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	Gastric MucinsIBA 01/2020
1	KetonesIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 11/2019
1	Prostate-Specific Antigen (Semenogelase)IBA 10/2019
1	Adenosine Monophosphate (AMP)IBA 12/2018
1	Toll-Like Receptor 1IBA 12/2018
1	Protein Kinases (Protein Kinase)IBA 12/2018
1	B7-H1 AntigenIBA 08/2018
1	LigandsIBA 08/2018
1	InterleukinsIBA 08/2018
1	Inflammation MediatorsIBA 08/2018
1	Interleukin-17 (Interleukin 17)IBA 08/2018
1	ChemokinesIBA 08/2018
1	CXC ChemokinesIBA 08/2018
1	CC ChemokinesIBA 08/2018
1	Carbon DisulfideIBA 01/2018
1	dimethyl sulfideIBA 01/2018
1	isopreneIBA 01/2018
1	pyridineIBA 01/2018
1	Pharmaceutical PreparationsIBA 09/2017
1	Interleukin-10 (Interleukin 10)IBA 05/2017
1	GoldIBA 08/2016
1	Biological ProductsIBA 03/2016
1	Peptides (Polypeptides)IBA 04/2015
1	Type C PhospholipasesIBA 12/2014
1	Mucin-1 (CA 15-3 Antigen)IBA 12/2014
1	CarcinogensIBA 10/2014
1	AutoantibodiesIBA 10/2014
1	Indicators and Reagents (Reagents)IBA 02/2012
1	AcidsIBA 02/2012
1	spasmolytic polypeptideIBA 01/2012
1	Toll-Like Receptor 4IBA 08/2011
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2011
1	NLR ProteinsIBA 08/2011
1	Protein Glutamine gamma Glutamyltransferase 2IBA 06/2011
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2010
1	AntralIBA 11/2009
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2008
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2008

Therapy/Procedure

7	Therapeutics 01/2021 - 12/2011
1	Gastrectomy 01/2016
1	Electronic Nose 11/2015
1	Secondary Prevention 10/2014
1	Lymph Node Excision (Lymph Node Dissection) 01/2010